Last updated: April 16, 2024
Sponsor: Mehrdad Mark Mofid
Overall Status: Completed
Phase
1
Condition
Pressure Ulcer
Surgery
Treatment
3M Steri-Strip
silk
Dermabond Prineo Skin Closure System
Clinical Study ID
NCT05508945
SSSID
20204292
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Exhibit fluency and literacy in English
- Exhibit adequate cognitive ability to consent to experimental research
- Ability to obtain pre-operative clearance from an unaffiliated primary care physicianprior to surgery as deemed necessary under M. Mark Mofid's predetermined standard ofcare guidelines for patients
Exclusion
Exclusion Criteria:
- Diagnosis of autoimmune disorders
- Diagnosis of allergy to DERMABOND Topical Skin Adhesive, STERI-STRIP skin closurestrips, polyester mesh, and/or silk
- Any acute or chronic condition that may inhibit ability to participate in the fullduration of study
- Inability to give informed consent
- Investigator decision that subject is no a suitable candidate
Study Design
Total Participants: 78
Treatment Group(s): 3
Primary Treatment: 3M Steri-Strip
Phase: 1
Study Start date:
August 23, 2022
Estimated Completion Date:
August 19, 2023
Study Description
Connect with a study center
San Diego Skin, Inc.
La Jolla, California 92037
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.